Memphasys Ltd

IG7

Company Profile

  • Business description

    Memphasys Ltd is an Australian reproductive biotechnology company developing and commercializing novel reproduction and fertility solutions for humans and animals. The products in its development pipeline include a range of devices, media, and in vitro diagnostic solutions. The company is currently focused on the commercialisation of its patented Felix System, a novel bio-separation technology for assisted reproduction, designed to revolutionise sperm separation in assisted reproductive technology (ART) by providing a rapid, gentle, and automated process. The group has only one operating segment, being Reproductive Technologies, the assets and liabilities of which are located in Australia.

  • Contact

    34-36 Richmond Road
    Level 1
    Homebush West
    SydneyNSW2140
    AUS

    T: +61 284157300

    https://www.memphasys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    Employees

    28

Stocks News & Analysis

stocks

ASX top pick remains cheap despite weaker consumer confidence

Consumer caution dents growth, shares look cheap.
stocks

Chart of the Week: Aussie dividend yields below 10-year average

Income opportunities remain beneath the surface.
stocks

Apple earnings: A smooth transition despite continued memory and supply headwinds

Shares fell as investors digested the latest earnings.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,954.9054.00-0.60%
CAC 408,177.89157.581.96%
DAX 4026,437.67573.052.22%
Dow JONES (US)53,356.121,569.403.03%
FTSE 10010,829.21190.781.79%
HKSE23,919.50393.531.67%
NASDAQ25,736.51364.501.44%
Nikkei 22562,188.63893.23-1.42%
NZX 50 Index13,957.01173.561.26%
S&P 5007,688.62119.701.58%
S&P/ASX 2008,834.5052.30-0.59%
SSE Composite Index3,686.1778.072.16%

Market Movers